BIOXCEL THERAPEUTICS, INC.
BIOXCEL THERAPEUTICS, INC. reported $5.2M in payments to physicians and teaching hospitals across 623 transactions in CMS Open Payments PY 2024.
Pharmaceutical payment transparency data for BIOXCEL THERAPEUTICS, INC.. Ranked #255 of 1,797 companies by total payments. Source: CMS Open Payments, Program Year 2024.
Payment Overview
Total Payments
$5.2M
0.0% of all payments
Transactions
623
$8.4K avg
Recipients
532
$9.8K avg
Industry Rank
#255
of 1,797 companies
What the Data Shows for BIOXCEL THERAPEUTICS, INC.
In Program Year 2024, BIOXCEL THERAPEUTICS, INC. reported $5,222,350.88 in payments to 532 physicians and teaching hospitals across 623 individual transactions — an average of $8.4K per transaction and $9.8K per recipient. That total places BIOXCEL THERAPEUTICS, INC. at rank #255 out of 1,797 companies in the CMS Open Payments database, representing 0.0% of all industry payments reported nationwide for the year. Payment volume at this scale is characteristic of manufacturers with broad prescriber engagement, active clinical research programs, or patented therapies generating ongoing royalty obligations.
The payment mix for BIOXCEL THERAPEUTICS, INC. spans 4 distinct categories defined by CMS — including general payments (consulting, speaker fees, meals, travel), research payments tied to clinical trials, and ownership or investment interests. The largest single category is "Consulting Fee" at $72.9K, accounting for 1.4% of the company's reported total and 10 transactions. This distribution matters because different payment types carry different regulatory and ethical implications: research funding supports clinical development, while general payments like meals and speaker fees have been studied for their correlation with prescribing patterns in peer-reviewed journals such as JAMA Internal Medicine.
Recipient concentration is another useful lens. The top 5 recipients of payments from BIOXCEL THERAPEUTICS, INC. received $0.00 combined — 0.0% of the company's total — with the remaining 100.0% distributed across the rest of the 532 recipients. A relatively distributed top-5 share suggests broader engagement across the prescriber community rather than concentration among a handful of high-value relationships. All figures above are drawn directly from the CMS Open Payments Public Use Files for PY2024 and are disclosed under the Physician Payments Sunshine Act; this page summarizes reported financial transfers and does not represent medical advice or judgment about individual prescribing decisions.
Payment Breakdown by Type
BIOXCEL THERAPEUTICS, INC. made 4 types of payments. "Consulting Fee" accounts for 1.4%.
1.4% · 10 transactions
0.4% · 493 transactions
0.3% · 11 transactions
0.1% · 18 transactions
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $72.9K | 10 | 1.4% |
| Food and Beverage | $21.3K | 493 | 0.4% |
| Compensation for Services Other Than Consulting | $17.9K | 11 | 0.3% |
| Travel and Lodging | $3.8K | 18 | 0.1% |
Payment Size Analysis
Average transaction size: $8.4K. Average per recipient: $9.8K.
Total Amount
$5,222,350.88
Avg per Transaction
$8.4K
Avg per Recipient
$9.8K
Payment Transparency Context
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.3B
across 1,797 companies
BIOXCEL THERAPEUTICS, INC. Share
0.0%
#255 by total payments
Related Healthcare Data
Explore related drug and healthcare provider data from other federal sources
PlainMeds — Drug Information
FDA drug data for 682 medications including interactions and alternatives. Look up drugs that BIOXCEL THERAPEUTICS, INC. may manufacture.
PlainDoctor — Provider Data
CMS provider data for 7M+ healthcare providers. Search for physicians who may be recipients of pharmaceutical payments.
PlainHospital — Hospital Quality
CMS Hospital Compare data for 5,400+ hospitals. View quality ratings for teaching hospitals that receive pharmaceutical payments.
PlainRecalls — FDA Recalls
FDA drug and device recall data. Check recall history for products manufactured by BIOXCEL THERAPEUTICS, INC..
PlainProcedure — Procedure Costs
Medicare procedure cost data for 9,200+ procedures. See what hospitals charge for medical procedures and how costs vary by state.
Learn More About Pharma Payments
In-depth guides on pharmaceutical industry payment transparency
Understanding Open Payments
How the Sunshine Act works and what payment data means for patients and physicians.
Drug Company Marketing Practices
How pharmaceutical companies market to healthcare professionals and why it matters.
Pharma Payment Types Explained
A guide to the different types of payments pharmaceutical companies make to physicians.
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to BIOXCEL THERAPEUTICS, INC.
OLYMPUS CORPORATION OF THE AMERICAS
MITSUBISHI TANABE PHARMA AMERICA, INC.
SPRINGWORKS THERAPEUTICS, INC.
INTERCEPT PHARMACEUTICALS, INC.
IMMEDICA PHARMA US, INC.
KLS-MARTIN L.P.
Frequently Asked Questions
How much did BIOXCEL THERAPEUTICS, INC. pay to physicians and hospitals in 2024? ▾
How many physicians received payments from BIOXCEL THERAPEUTICS, INC.? ▾
What types of payments did BIOXCEL THERAPEUTICS, INC. make? ▾
How does BIOXCEL THERAPEUTICS, INC. rank among pharmaceutical companies? ▾
What is the average payment size from BIOXCEL THERAPEUTICS, INC.? ▾
Are the top recipients concentrated for BIOXCEL THERAPEUTICS, INC.? ▾
Where does the payment data for BIOXCEL THERAPEUTICS, INC. come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.3B across 1,797 companies.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
